SLXN
SLXN
NASDAQ · Biotechnology

Silexion Therapeutics Corp

$0.42
-0.04 (-8.65%)
As of Aug 14, 10:26 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +8,524.5% upside
Low Target $26.81
Average Target $36.24
High Target $52.45
Current Price $0.42
Current
$0.42
Target
$36.24
$26.81 $36.24 avg $52.45
Scenario Analysis
Bear Case
$26.81
6,280.3%
Low target
Base Case
$36.24
+8,524.5%
Avg target
Bull Case
$52.45
+12,382.2%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$89.80
-99.5% from high
52-Week Low
$1.50
+-72.0% from low
Target vs 52W High
$36.24
-59.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%